Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|vaccine

    #599740

    IATE #3621480
    vacsaín leáphróitéine Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    vacsaín leápheiptíde Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    fusion peptide vaccine | fusion protein vaccine
    en
    Sainmhíniú recombinant vaccine against a virus which targets the fusion proteins of the virus, i.e. those which mediate fusion of viral and cellular membranes Tagairt COM-Terminology Coordination, based on: - Samantha Black. 'Variant-resistant COVID-19 vaccines could be effective, cheap to make' (19.10.2021). The Science Advisory Board. April 19, 2021- Molecular Targeting Technologies, Inc. (MTTI). 'Fusion Protein Vaccine Technology' (19.10.2021)